Clinical Trials Logo

Clinical Trial Summary

In patients with addiction to a substance, an increase in activity in the prefrontal cortex induced by transcranial Direct Current Stimulation -tDCS (non-invasive technique, modulating cortical activity by applying low-intensity electrical currents between two electrodes),may help reduce craving in people addicted to alcohol and tobacco. By analogy with addictive behavior with a substance, the craving observed in certain behavioral addictions would involve the same neural circuits. The main hypothesis is to reduce the sexual craving associated with the viewing of erotic images during active brain stimulation compared to placebo stimulation. Functional MRI will allow to better understand the neural circuits involved in sexual addiction and in the expected inhibition of sexual arousal by tDCS in sexual addictions during visualization erotic images.


Clinical Trial Description

The concept of sexual addiction appeared in American literature about 20 years ago. The term sexual addiction describes an excessive, increasing, and especially uncontrolled frequency of sexual behavior, as a conventional rule, associated with a compelling and irrepressible sexual desire (craving), which persists in spite of the possible negative consequences and personal suffering of the subject. The prevalence of this condition is estimated to be approximately 3-6% in the general population in the United States, it is independent of the socio-cultural environment. The pathophysiology of sexual addictions remains very poorly understood. Numerous studies have focused on substance addictions and their pathophysiology. The mesolimbic dopaminergic system plays a major role in addictive behavior. The prefrontal cortex and the basolateral region of the amygdala play an important role in the craving and may cause relapse in subjects. In subjects with sexual addiction, only one controlled study has been conducted on the role of antidepressant treatment in the reduction of craving. The objective of the study is not only to evaluate the efficacy of tDCS neurostimulation in this disorder but also to identify the brain structures involved in this addictive disorder. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04923451
Study type Interventional
Source Centre Hospitalier St Anne
Contact Leo Malandain, MD
Phone 0033158411678
Email leo.malandain@aphp.fr
Status Not yet recruiting
Phase N/A
Start date July 1, 2021
Completion date October 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05861752 - Paraphilic Disorders and Other Conditions With Risk for Sexual Violence: a Case-control Study
Enrolling by invitation NCT02844985 - A Study of Gene Polymorphisms Associated With Specific Presentations of Sexual Addiction
Not yet recruiting NCT05483426 - Prevalence of Sexual Addiction in an Inmate Population at the Muret Detention Center in Haute-Garonne (PAS-CD) N/A